These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. MRI predictors of cognitive outcome in early multiple sclerosis. Deloire MS, Ruet A, Hamel D, Bonnet M, Dousset V, Brochet B. Neurology; 2011 Mar 29; 76(13):1161-7. PubMed ID: 21444901 [Abstract] [Full Text] [Related]
24. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis. Kizlaitienė R, Kaubrys G, Giedraitienė N, Ramanauskas N, Dementavičienė J. Med Sci Monit; 2017 Feb 01; 23():588-597. PubMed ID: 28145395 [Abstract] [Full Text] [Related]
35. The association between cognition and motor performance is beyond structural damage in relapsing-remitting multiple sclerosis. Mistri D, Cacciaguerra L, Storelli L, Meani A, Cordani C, Rocca MA, Filippi M. J Neurol; 2022 Aug 01; 269(8):4213-4221. PubMed ID: 35278104 [Abstract] [Full Text] [Related]
39. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. Giugni E, Pozzilli C, Bastianello S, Gasperini C, Paolillo A, Koudriavtseva T, Frontoni M, Farina D, Bozzao L. Mult Scler; 1997 Aug 01; 3(4):221-5. PubMed ID: 9372503 [Abstract] [Full Text] [Related]
40. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N. Neurology; 2004 Jul 13; 63(1):89-93. PubMed ID: 15249616 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]